cancer; chronic lymphocytic leukemia; chronic myelogenous leukemia; distress/supportive care; Hodgkin lymphoma; lung cancer screening; malignant pleural mesothelioma; melanoma; multiple myeloma; myelodysplastic syndromes*; myeloproliferative neoplasms
Search Results
NCCN News
Current Concepts in the Evaluation and Treatment of Patients With Diffuse Malignant Peritoneal Mesothelioma
Keli Turner, Sheelu Varghese, and H. Richard Alexander
. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma . J Clin Oncol 2003 ; 21 : 2636 — 2644 . 32 Janne PA Wozniak AJ Belani CP . Open-label study of pemetrexed
Non–Small Cell Lung Cancer, Version 2.2013
David S. Ettinger, Wallace Akerley, Hossein Borghaei, Andrew C. Chang, Richard T. Cheney, Lucian R. Chirieac, Thomas A. D'Amico, Todd L. Demmy, Ramaswamy Govindan, Frederic W. Grannis Jr, Stefan C. Grant, Leora Horn, Thierry M. Jahan, Ritsuko Komaki, Feng-Ming (Spring) Kong, Mark G. Kris, Lee M. Krug, Rudy P. Lackner, Inga T. Lennes, Billy W. Loo Jr, Renato Martins, Gregory A. Otterson, Jyoti D. Patel, Mary C. Pinder-Schenck, Katherine M. Pisters, Karen Reckamp, Gregory J. Riely, Eric Rohren, Theresa A. Shapiro, Scott J. Swanson, Kurt Tauer, Douglas E. Wood, Stephen C. Yang, Kristina Gregory, and Miranda Hughes
lung cancer (eg, squamous cell carcinoma, large cell carcinoma). 21 Other types of thoracic cancer are discussed in the NCCN Guidelines for Malignant Pleural Mesothelioma, Small Cell Lung Cancer, and Thymomas and Thymic Carcinomas (to view the most
Chemoradiotherapy Versus Chemotherapy Alone for Unresected Nonmetastatic Gallbladder Cancer: National Practice Patterns and Outcomes
Vivek Verma, Swati M. Surkar, Eric D. Brooks, Charles B. Simone II, and Chi Lin
Cancer Data Base report on pneumonectomy versus lung-sparing surgery for malignant pleural mesothelioma . J Thorac Oncol 2017 ; 12 : 1704 – 1714 . 21. Haque W Verma V Butler EB Teh BS . Definitive chemoradiation at high volume facilities is
Part 3: Abstracts From the NCCN 19th Annual Conference: Advancing the Standard of Cancer Care™
for non-Hodgkin’s lymphoma, non-small cell lung cancer/malignant pleural mesothelioma/thymomas, and colon/rectal/anal cancers. Sources of the requests were internal NCCN Member Institutions (77%; n=318), external sources alone (12%; n=48), and
Abstracts From the NCCN 2020 Virtual Annual Conference
. CLINICAL ONCOLOGY CLO20-030: Sex-Based Disparities in Receipt of Care and Survival in Malignant Pleural Mesothelioma Andrew R. Barsky, MD a ; Christopher A. Ahern, PhD b ; Sriram Venigalla, MD a ; Vivek Verma, MD c ; Emily J. Anstadt, MD, PhD a
Addition of Definitive Radiotherapy to Chemotherapy in Patients With Newly Diagnosed Metastatic Nasopharyngeal Cancer
Vivek Verma, Pamela K. Allen, Charles B. Simone II, Hiram A. Gay, and Steven H. Lin
Cancer Data Base report on pneumonectomy versus lung-sparing surgery for malignant pleural mesothelioma . J Thorac Oncol 2017 ; 12 : 1704 – 1714 . 32. Haque W Verma V Fakhreddine M . Addition of chemotherapy to definitive radiotherapy for
Low Rates of Chemotherapy Use for Primary, High-Grade Soft Tissue Sarcoma: A National Cancer Database Analysis
Danielle S. Graham, Mykola Onyshchenko, Mark A. Eckardt, Benjamin J. DiPardo, Sriram Venigalla, Scott D. Nelson, Bartosz Chmielowski, Arun S. Singh, Jacob E. Shabason, Fritz C. Eilber, and Anusha Kalbasi
-Mercado F , Borgella JD , Berz D , . Disparities in compliance with national guidelines for the treatment of malignant pleural mesothelioma . Ann Thorac Surg 2019 ; 108 : 889 – 896 . 10.1016/j.athoracsur.2019.03.052 31004585 47. Birkmeyer JD
Sequential Versus Concurrent Chemoradiation Therapy by Surgical Margin Status in Resected Non–Small Cell Lung Cancer
Vivek Verma, Amy C. Moreno, Waqar Haque, Penny Fang, and Steven H. Lin
chemotherapy to radiation therapy for stage I nasopharyngeal cancer . Acta Oncol 2018 ; 57 : 257 – 261 . 21. Verma V Ahern CA Berlind CG . National Cancer Data Base report on pneumonectomy versus lung-sparing surgery for malignant pleural
The Relevance of Hereditary Cancer Risks to Precision Oncology: What Should Providers Consider When Conducting Tumor Genomic Profiling?
Rishi Jain, Michelle J. Savage, Andrea D. Forman, Reetu Mukherji, and Michael J. Hall
Ziltener G Nackaerts K . Prevalence of BRCA-1 associated protein 1 germline mutation in sporadic malignant pleural mesothelioma cases . Lung Cancer 2015 ; 87 : 77 – 79 . 40. Ramus SJ Song H Dicks E . Germline mutations in the BRIP1, BARD1